Terug
Dagbereik
€ 180,68
€ 185,07
52-Weeksbereik
€ 95,49
€ 198,00
Volume
1.476.713
50D / 200D Gem.
€ 173,53
/
€ 144,04
Vorige Slotkoers
€ 182,32
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -32,0 | 0,3 |
| P/B | 2,6 | 2,9 |
| ROE % | -8,5 | 3,7 |
| Net Margin % | -8,4 | 3,8 |
| Rev Growth 5Y % | 8,4 | 10,0 |
| D/E | 1,3 | 0,2 |
Koersdoel Analisten
Hold
€ 207,86
+12.4%
Low: € 170,00
High: € 235,00
Forward K/W
7,6
Forward WPA
€ 23,93
WPA Groei (sch.)
+0,0%
Omzet Sch.
4,4 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 31,98
€ 30,75 – € 33,42
|
6 B | 2 |
| FY2029 |
€ 30,88
€ 29,69 – € 32,27
|
5,8 B | 2 |
| FY2028 |
€ 26,64
€ 19,61 – € 32,84
|
5,2 B | 4 |
Belangrijkste Punten
Revenue grew 8,37% annually over 5 years — modest growth
Earnings declined -163,58% over the past year
Generating 1,30B in free cash flow
PEG of 0,18 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 3,49%
Capital efficient — spends only 1,38% of revenue on capex
Groei
Revenue Growth (5Y)
8,37%
Revenue (1Y)4,88%
Earnings (1Y)-163,58%
FCF Growth (3Y)10,20%
Kwaliteit
Return on Equity
-8,47%
ROIC1,73%
Net Margin-8,35%
Op. Margin5,26%
Veiligheid
Debt / Equity
1,26
Current Ratio1,86
Interest Coverage1,15
Waardering
P/E Ratio
-31,98
P/B Ratio2,64
EV/EBITDA68,72
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4,88% | Revenue Growth (3Y) | 5,50% |
| Earnings Growth (1Y) | -163,58% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 8,37% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4,27B | Net Income (TTM) | -356,15M |
| ROE | -8,47% | ROA | -3,05% |
| Gross Margin | 88,21% | Operating Margin | 5,26% |
| Net Margin | -8,35% | Free Cash Flow (TTM) | 1,30B |
| ROIC | 1,73% | FCF Growth (3Y) | 10,20% |
| Safety | |||
| Debt / Equity | 1,26 | Current Ratio | 1,86 |
| Interest Coverage | 1,15 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -31,98 | P/B Ratio | 2,64 |
| P/S Ratio | 2,67 | PEG Ratio | 0,18 |
| EV/EBITDA | 68,72 | Dividend Yield | 0,00% |
| Market Cap | 11,39B | Enterprise Value | 15,42B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4,27B | 4,07B | 3,83B | 3,66B | 3,09B |
| Net Income | -356,15M | 560,12M | 414,83M | -224,06M | -328,95M |
| EPS (Diluted) | -5,84 | 8,65 | 6,10 | -3,58 | -5,51 |
| Gross Profit | 3,76B | 3,62B | 3,40B | 3,12B | 2,65B |
| Operating Income | 224,42M | 716,63M | 578,58M | -65,53M | 170,28M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 11,66B | 12,01B | 11,39B | 10,84B | 12,30B |
| Total Liabilities | 7,34B | 7,92B | 7,66B | 7,75B | 8,33B |
| Shareholders' Equity | 4,32B | 4,09B | 3,74B | 3,09B | 3,97B |
| Total Debt | 5,42B | 6,16B | 5,79B | 5,81B | 6,15B |
| Cash & Equivalents | 1,39B | 2,41B | 1,51B | 881,48M | 591,45M |
| Current Assets | 4,17B | 4,63B | 3,44B | 2,61B | 2,61B |
| Current Liabilities | 2,24B | 1,04B | 1,54B | 933,19M | 809,30M |